The Competitive Edge: Catalyxx
Q: What was the reason for founding your organization – what was the open niche you saw that could be addressed with a new product or service? What was the problem, or gap, or opportunity?
Catalyxx was formed with the purposes of owning the exclusive rights to a technology, originally developed by Abengoa Bioenergy, that converts ethanol into n-butanol, n-hexanol, n-octanol, and n-decanol by means of chemical catalysis.
The technology is protected by a family of seven different patents covering catalyst formulation and use and process for the production of the chemicals.
Catalyxx provides value to ethanol by its conversion into higher alcohols avoiding the typical scalation problems of the biological route.
Moreover, the cost of production is significantly lower than the petrochemical process and it reduces GHG up to 85%.
The technology has been extensively proven at lab, bench and pilot scales. It has accumulated more than 30,000 hours of testing and the process engineering package is already developed and ready for commercialization.
The catalyst has been produced at an industrial scale and is also ready for commercial deployment.
Q: Tell us about your organization. What do you do?
Our technology converts ethanol into n-butanol, n-hexanol, n-octanol, and n-decanol.